We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HNST icon
2551
The Honest Company
HNST
$540M
$22.9K ﹤0.01%
+7,847
New +$23.3K
TS icon
2552
Tenaris
TS
$26.6B
$22.6K ﹤0.01%
742
– –
XERS icon
2553
Xeris Biopharma Holdings
XERS
$1.52B
$22.3K ﹤0.01%
9,930
– –
OBT icon
2554
Orange County Bancorp
OBT
$524M
$22.3K ﹤0.01%
844
– –
WOW
2555
DELISTED
WideOpenWest
WOW
$22.2K ﹤0.01%
4,110
– –
FBIZ icon
2556
First Business Financial Services
FBIZ
$601M
$22.2K ﹤0.01%
601
– –
TLS icon
2557
Telos
TLS
$344M
$22.2K ﹤0.01%
+5,513
New +$20.9K
SPIB icon
2558
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
$22.1K ﹤0.01%
680
– –
BWB icon
2559
Bridgewater Bancshares
BWB
$620M
$22.1K ﹤0.01%
1,907
– –
ATNI icon
2560
ATN International
ATNI
$491M
$22K ﹤0.01%
967
– –
TCRX icon
2561
TScan Therapeutics
TCRX
$52.3M
$22K ﹤0.01%
+3,762
New +$29.6K
JMSB icon
2562
John Marshall Bancorp
JMSB
$328M
$22K ﹤0.01%
1,260
– –
SEI
2563
Solaris Energy Infrastructure
SEI
$3.94B
$21.8K ﹤0.01%
2,541
– –
SPOK icon
2564
Spok Holdings
SPOK
$230M
$21.7K ﹤0.01%
1,468
– –
RCKY icon
2565
Rocky Brands
RCKY
$353M
$21.7K ﹤0.01%
588
– –
MAMA icon
2566
Mama's Creations
MAMA
$790M
$21.7K ﹤0.01%
+3,224
New +$19.6K
NKTR icon
2567
Nektar Therapeutics
NKTR
$2.57B
$21.7K ﹤0.01%
+1,166
New +$24.6K
ADCT icon
2568
ADC Therapeutics
ADCT
$134M
$21.7K ﹤0.01%
+6,859
New +$27.3K
AVD icon
2569
American Vanguard Corp
AVD
$62.8M
$21.6K ﹤0.01%
2,506
– –
CLMB icon
2570
Climb Global Solutions
CLMB
$532M
$21.5K ﹤0.01%
1,372
– –
INBK icon
2571
First Internet Bancorp
INBK
$256M
$21.5K ﹤0.01%
+795
New +$24K
INZY
2572
DELISTED
Inozyme Pharma
INZY
$21.4K ﹤0.01%
4,805
– –
PGEN icon
2573
Precigen
PGEN
$2.32B
$21.4K ﹤0.01%
13,542
– –
RVNC
2574
DELISTED
Revance Therapeutics, Inc.
RVNC
$21.3K ﹤0.01%
8,289
– –
LENZ
2575
LENZ Therapeutics
LENZ
$145M
$21.3K ﹤0.01%
1,231
+900
+272% +$15.7K
101 102
103
104 105

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.